The 10 latest articles on Biotech: CRISPR, Longevity and Brain-Computer Interfaces come from 9 sources, published between Nov 10 and Nov 12. Most come from BioXconomy (2).
Organizations: Google (3), Informa Life Sciences (2)
Places: US (2), Washington (2), United States (2), Beijing (2)
Growth Strategy Innovation Showcase features the latest presentations from Informa Life Sciences' global Partnering and Investment events, offering exclusive viewer access for six months.MEDiC Life Sciences presents at BIO-Europe 2026 November 12, 2026 schedule15 Min View@Informa Life ScienceslinkPRESENTER: Kyuho Han is CEO…
MEXICO - Spanish USA - English BRAZIL - Portuguese APAC - Traditional Chinese News provided by Evident 13 Nov, 2026, 06:25 IST The new detector extends Evident's FLUOVIEW™FV5000 confocal platform, helping researchers capture fast-changing biological events simultaneously across up to four channels with data ready for quantitative…
Interviews David Mařák, CTO and Co-Founder of YORD – Interview Series Published November 12, 2026 By Antoine Tardif, CEO & Founder of Unite.AI Add Unite.AI to your preferred sources on Google David Mařák, CTO and Co-Founder of YORD. David Mařák is CTO…
November 12, 2026 4:30 PMRecent News Photo from of the University of Notre Dame. News Release NOTRE DAME – The University of Notre Dame plans to establish a Department of Bioengineering in July 2027, expanding its research and academic offerings in a field that combines…
NEWS 12 November 2026 Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body Earlier CRISPR treatments require removal of a participant’s cells, a complex and costly approach. By Heidi Ledford0 Heidi Ledford Heidi Ledford reports for…
Published: November 10 2026 Last updated: November 10 2026 Kami Kountcheva | An experimental gene therapy has been trialled in three adults, with early findings showing few side effects and more than 90% reduction in seizures. An experimental new gene therapy is showing promising results in…
Adults Living with NT1 Can Now be Prescribed ORZEYFUL, a New First-in-Class Orexin Medicine that Treats the Disease Holistically ORZEYFUL has the Potential to Redefine the Standard of Care by Targeting the Underlying Orexin Deficiency Associated with NT1 Takeda (TSE:4502/NYSE:TAK)…
Growth Strategy Innovation Showcase features the latest presentations from Informa Life Sciences' global Partnering and Investment events, offering exclusive viewer access for six months.Inovis AG presents at BIO-Europe 2026 November 12, 2026 Informa Life ScienceslinkPRESENTER: Ashlyn Sadrick Stien, Head AI Innovation, Inovis…
ShowsThe Morning Blend Why Science Matters: The Medical Breakthroughs Patients Are Waiting For Bayer Posted FacebookNextdoorXThreadsRedditLinkedInEmailWhatsAppMessenger Add TMJ4 as a Google Preferred Source Scientific discoveries can lead to treatments that change lives, but what happens when progress slows? A new Harris…
Biotech: CRISPR, Longevity and Brain-Computer Interfaces in Science and Technology: the news, the names and what changed.
An article joins this feed when it matches these terms. Each one is also a search of its own.